Home › Chronische lymfatische leukemie › Oregon › Portland
Chronische lymfatische leukemie klinische studies in Portland, OR
10 studies voor Chronische lymfatische leukemie zoeken deelnemers op locaties in en rond Portland (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RekruterenFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mijl verwijderd
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RekruterenFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
RekruterenFase 3
- Oregon Health and Science University ( Site 5425), Portland
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
RekruterenObservatieonderzoek
- OHSU Knight Cancer Institute, Portland
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RekruterenFase 1/2
- Research Site, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- Oregon Health & Science University, Portland
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruterenFase 1
- Oregon Health and Science University - Knight Cancer Institute, Portland
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
RekruterenFase 1
- OHSU Knight Cancer Institute, Portland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruterenFase 1
- Oregon Health & Science University, Portland
Chronische lymfatische leukemie studies in andere steden
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
- Cincinnati, OH14 studies
Andere studies in Portland
- Niet-kleincellige longkanker46 studies
- Kanker (alle vormen)34 studies
- Prostaatkanker33 studies
- Borstkanker33 studies
- Metastatische kanker29 studies
- Colorectale kanker28 studies
- Eierstokkanker27 studies
- Longkanker26 studies
- Acute myeloïde leukemie25 studies
- Endometriumkanker24 studies
- Plaveiselcelcarcinoom van hoofd en hals19 studies
- Aldermeesklierkanker19 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.